Perillaldehyde 1,2-epoxide Loaded SLN-Tailored mAb: Production, Physicochemical Characterization and In Vitro Cytotoxicity Profile in MCF-7 Cell Lines.
Compritol ATO 888
MCF-7 cells
cationic SLN
perillaldehyde 1,2-epoxide
streptavidin adsorption
Journal
Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003
Informations de publication
Date de publication:
16 Feb 2020
16 Feb 2020
Historique:
received:
20
01
2020
revised:
09
02
2020
accepted:
13
02
2020
entrez:
22
2
2020
pubmed:
23
2
2020
medline:
23
2
2020
Statut:
epublish
Résumé
We have developed a new cationic solid lipid nanoparticle (SLN) formulation, composed of Compritol ATO 888, poloxamer 188 and cetyltrimethylammonium bromide (CTAB), to load perillaldehyde 1,2-epoxide, and surface-tailored with a monoclonal antibody for site-specific targeting of human epithelial growth receptor 2 (HER2). Perillaldehyde 1,2-epoxide-loaded cationic SLN (c
Identifiants
pubmed: 32079103
pii: pharmaceutics12020161
doi: 10.3390/pharmaceutics12020161
pmc: PMC7076521
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : Conselho Nacional de Desenvolvimento Científico e Tecnológico, Coordenação de Aperfeiçoamento de Pessoal de Nível Superior and Fundação de Apoio à Pesquisa e Inovação Tecnológica do Estado de Sergipe
ID : CNPq, CAPES and FAPITEC/SE
Organisme : Portuguese Science and Technology Foundation, Ministry of Science and Education (FCT/MEC) through national funds, and co-financed by FEDER, under the Partnership Agreement PT2020
ID : M-ERA-NET-0004/2015-PAIRED and UIDB/04469/2020
Références
J Carcinog. 2006 May 11;5:14
pubmed: 16689993
Saudi J Biol Sci. 2013 Jul;20(3):235-9
pubmed: 23961240
Eur J Pharm Biopharm. 2014 May;87(1):1-18
pubmed: 24530885
Int J Mol Sci. 2016 Jan 04;17(1):
pubmed: 26742032
Int J Pharm. 2014 Aug 25;471(1-2):18-27
pubmed: 24836663
Am J Cancer Res. 2015 Apr 15;5(5):1580-93
pubmed: 26175929
Handb Exp Pharmacol. 2010;(197):115-41
pubmed: 20217528
Eur J Pharm Sci. 2019 Feb 1;128:27-35
pubmed: 30472221
Molecules. 2019 Jul 24;24(15):
pubmed: 31344802
Eur J Pharm Biopharm. 2016 Nov;108:235-252
pubmed: 27519829
Eur J Pharm Biopharm. 2006 Feb;62(2):155-62
pubmed: 16290122
Int J Mol Sci. 2020 Feb 20;21(4):
pubmed: 32093358
Int J Pharm. 2014 Jan 30;461(1-2):64-73
pubmed: 24275449
Int J Pharm. 2018 Oct 5;549(1-2):261-270
pubmed: 30075252
Int J Pharm. 2016 Apr 11;502(1-2):161-9
pubmed: 26921515
Int J Nanomedicine. 2015 Sep 28;10:6055-74
pubmed: 26451111
Polymers (Basel). 2019 Nov 19;11(11):
pubmed: 31752417
J Mater Sci Mater Med. 2010 Dec;21(12):3129-40
pubmed: 21046203
Prog Mol Biol Transl Sci. 2011;104:299-323
pubmed: 22093222
Int J Pharm. 2011 Nov 28;420(2):341-9
pubmed: 21907778
Colloids Surf B Biointerfaces. 2018 Nov 1;171:501-505
pubmed: 30081382
Eur J Med Chem. 2013 Feb;60:249-53
pubmed: 23313633
Curr Med Chem. 2019;26(24):4537-4558
pubmed: 30378485
J Appl Toxicol. 2014 Apr;34(4):395-403
pubmed: 24243595
Int J Mol Sci. 2019 Nov 06;20(22):
pubmed: 31698783
Molecules. 2015 Jul 21;20(7):13264-80
pubmed: 26197313
Int J Pharm. 2018 Dec 20;553(1-2):428-440
pubmed: 30385373
Int J Pharm. 2003 Mar 18;254(1):83-7
pubmed: 12615415
Mol Cancer. 2015 May 15;14:105
pubmed: 25976744